Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Hyperthyroidism”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 775 records · Page 43Linked to original sources

[Diffuse nonautoimmune hyperthyroidism].

Diffuse non auto-immune hyperthyroidism is a rare entity, classically restricted to cases with hypersecretion of TSH, hCG or related molecule and to a few reports of proven paraneoplastic origin. The authors try to individualize another type of diffuse hyperthyroidism, previously considered to belong to Graves' disease, but without any sign of disimmunity. They present a familial form with several hyperthyroidic patients who showed neither change in humoral immunity nor immunological abnormality within the thyroid gland, even in those that were operated upon without prior antithyroid medication. Similar findings occurred within several series of hyperthyroid glands separately studied by the authors, using different techniques: histomorphometric quantification of lymphocytic infiltration, immunofluorescence in the search of IgG, IgA, IgM, C1 q, C3 and C9 fractions, or T-lymphocyte subsets. These techniques generally tend to yield positive results, that agree with an auto-immune pathogenesis, but totally negative findings do occur. This type of diffuse hyperthyroidism should be delineated from the common auto-immune type, and might be called toxic hyperplasia.

Antibody Formation↗

[Iodine-induced hyperthyroidism in the aged. 2. Pathomechanism, differential diagnosis and therapy problems].

The occurrence of multiple processes in elderly patients brings a high risk for diagnostic or therapeutic induced iodine-hyperthyroidism. Often an atypical form of hyperthyroidism without classical symptoms is induced. The cause of iodine-induced hyperthyroidism exists mostly in autonomous tissue beyond a "critical volume" in localized or disseminated form. If the deficiency of iodine in endemic goitre areas is substituted by iodine-application, hypermetabolism of autonomous tissue causes hyperthyroidism. The pathomechanism of autonomy and iodine-induced hyperthyroidism is not completely known. General iodine salt prophylaxis will bring less amounts of autonomous goitres. Some differential diagnostic possibilities for avoiding iodine-contamination in the elderly patients and therapeutic consequences after unavoidable iodine-application are described.

Aged↗

[Preclinical hyperthyroidism in thyroid invasion by tumors of other organs].

Inclusion of that degree of supranormal autonomous thyroid function which induces TRH-refractoriness without clinical hyperthyroidism (i.e. preclinical hyperthyroidism), and a high prevalence of autonomously functioning multinodular goiter results in a high incidence of hyperthyroidism in thyroid malignancy. In a series of 56 consecutive patients with differentiated thyroid carcinoma 17 (30%) had a coincidental multinodular goiter with preclinical (21%) or overt (9%) hyperthyroidism. Furthermore, preclinical hyperthyroidism was found in 2 out of 5 patients with secondary carcinoma and malignant lymphoma of the thyroid respectively. These patients' cases are presented in detail; they had no concomitant nodular goiter or signs of immunogenic autonomous thyroid function. The observation confirms the facultative occurrence of supranormal thyroid hormone release induced by tumor invasion and morphologic destruction of follicles.

Adenocarcinoma↗

[Serum levels and kinetics of digoxin in patients with hyperthyroidism (author's transl)].

The mechanism of reduced sensitivity to digitalis in patients with hyperthyroidism has been attributed to a change of intrinsic myocardial function and/or to altered pharmacokinetics of cardiac glycosides. Digoxin kinetics have been studied in hyperthyroid and 8 euthyroid patients after a single oral and i.v. dose at steady-state. Plasma and urinary digoxin concentrations were determined by radioimmunoassay. A significantly mean lower serum digoxin concentration was found in hyperthyroid patients, both after a single oral drug administration and at the steady-stage. A decreased digoxin absorption could not account for this finding, since both the percentage of gastrointestinal uptake of the drug and maximal serum concentration did not differ in hyperthyroid patients as compared to controls. Hyperthyroid subjects showed, on the contrary, an expended distribution volume and a significantly higher excretion, as documented by a lower drug half-life, by the increase of the elimination constant and urinary digoxin output.

Adult↗

Radioiodine treatment of 524 cats with hyperthyroidism.

OBJECTIVE: To evaluate a protocol for subcutaneous radioiodine treatment of cats with hyperthyroidism in which the dose was determined on the basis of severity of the cat's clinical signs, thyroid tumor size, and magnitude of the serum thyroxine (T4) concentration. DESIGN: Prospective case series. ANIMALS: 524 cats with hyperthyroidism. PROCEDURE: A scoring system based on 3 factors (severity of clinical signs, size of the thyroid gland, and magnitude of the serum T4 concentration) was used to select the dose of radioiodine to be administered subcutaneously. RESULTS: On the basis of the scoring system, 310 (59%) cats were treated with a low dose of radioiodine (< 3.5 mCi; median, 3.0 mCi), 158 (30%) were treated with a moderate dose (3.5 to 4.4 mCi; median, 4.0 mCi), and 56 (11%) were treated with a high dose (> or = 4.5 mCi; median, 5.0 mCi). At time of discharge from the hospital, serum T4 concentration was still high in 80 (15.3%) cats, but by 6 months after administration of radioiodine, the serum T4 concentration had decreased to within or below reference range in all but 8 (1.5%) cats with persistent hyperthyroidism. Many cats had low serum T4 concentrations at some time after radioiodine treatment, but only 11 (2.1%) cats developed clinical and clinicopathologic features of hypothyroidism and required supplementation with L-thyroxine. Thirteen (2.5%) cats had a relapse of hyperthyroidism 1.1 to 6.5 years after initial radioiodine treatment. Overall, the response to treatment was considered good in 94.2% of the cats. Median survival time in the cats was 2.0 years; the percentage of cats alive after 1, 2, and 3 years of treatment was 89, 72, and 52%, respectively. CLINICAL IMPLICATIONS: Results of the study suggest that this method of dose estimation works well and that subcutaneous administration of radioiodine provides a safe and effective means of treating hyperthyroidism in cats.

Animals↗

Hyperthyroidism in adults: variable clinical presentations and approaches to diagnosis.

BACKGROUND: Hyperthyroidism is a disease that has various symptoms and can present in many ways. In the elderly patient hyperthyroidism often is not expressed in the classical manner. A case report of a middle-aged man who had hyperthyroidism with only one symptom is detailed. METHODS: A literature review utilizing MEDLINE files from 1988 to the present, as well as current textbooks of medicine and endocrinology, was used to prepare this report. Keywords for the search were "hyperthyroidism," "symptoms," "unintentional weight loss," and "differential diagnosis." RESULTS AND CONCLUSIONS: The clinical presentation of hyperthyroidism can vary from almost asymptomatic to apathetic in appearance to a marked hyperdynamic physiologic response. Family physicians must be well informed of this variation in disease expression. Overlooking the diagnosis of this relatively easily treated condition can be detrimental to patient care and expensive.

Adult↗

Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism.

OBJECTIVE: To determine whether control of hyperthyroidism during pregnancy reduces the risk of low birth weight infants and severe preeclampsia. METHODS: Labor, delivery, and postpartum records of 181 hyperthyroid women were reviewed for maternal and fetal outcomes. Subjects were separated into three groups based on their thyroid status: controlled (n = 34), including women who were euthyroid at presentation and delivery; controlled during pregnancy (n = 90), including women who were hyperthyroid at presentation and euthyroid at delivery; and uncontrolled (n = 57), including women who were hyperthyroid at presentation and delivery. RESULTS: The risk of low birth weight infants was 0.74 (95% confidence interval [CI] 0.18-3.08) among controlled women, 2.36 (95% CI 1.36-4.12) among women who were controlled during pregnancy, and 9.24 (95% CI 5.47-15.6) among women who were uncontrolled during pregnancy compared to the incidence among nonhyperthyroid mothers. The risk of severe preeclampsia was significantly higher (odds ratio 4.74, 95% CI 1.14-19.7) among uncontrolled women compared with those who were controlled during their pregnancies. Elevated TSH-receptor antibody levels were not related to preeclampsia. Maternal thioamide therapy did not adversely affect neonatal outcomes. CONCLUSION: Lack of control of hyperthyroidism significantly increases the risk of low birth weight infants and severe preeclampsia.

Female↗

[Hyperthyroidism at elevated thyreostimulin. A case with pituitary resistance to thyroid hormones].

Simultaneous elevation of thyreostimulin and thyroid hormones values, when associated with clinical hyperthyroidism, raises a dual problem of diagnosis and treatment. We report a case of hyperthyroidism with elevated thyreostimulin in a young adult man. The values of free triiodothyronin and free thyroxin were elevated and the thyroxin binding globulin was normal. A normal pituitary tomodensitometry, the normal values of the alpha sub-unit of thyreostimulin and the dynamic tests of thyreostimulin secretion allowed us to rule out the hypothesis of a pituitary adenoma. Non-tumoral inappropriate secretions of thyreostimulin are at present regarded as syndromes of resistance to thyroid hormones. Their biological translation is a simultaneous elevation of thyreostimulin and thyroid hormones. Peripheral resistance, which is rarely complete, finds its expression in clinical hyperthyroidism or in normal clinical condition, whereas pituitary resistance, which causes the lack of feedback on the secretion of thyreostimulin expresses itself by clinical hyperthyroidism, sometimes with goitre owing to the trophic action of thyreostimulin on the thyroid. Generalized syndromes of resistance are the most common. Our patient had a selective pituitary resistance to thyroid hormones and less than thirty cases are reported in the literature. Treatment with a beta-blocker remains indicated when facing clinical evidence for hyperthyroidism and oral triiodothyronin seems to be able to slow down the inappropriate secretion of thyreostimulin. Regarding our patient who experienced a clinical and biological relapse after the stopping of the treatment, we join many authors who recommend a prolonged treatment.

Adult↗

[Levels of free fatty acids in plasma, K coefficient and insulin secretion stimulated by intravenous glucose load in patients with hyperthyroidism taking propranolol or acebutolol].

UNLABELLED: The aim of this study was to determine the relationships between plasma free fatty acids levels (FFA) and impaired glucose tolerance in hyperthyroid patients in basal condition and after propranolol and acebutolol treatment, i.e. after lipolytic blockade leading to a decrease in plasma FFA levels. 31 untreated hyperthyroid patients and 12 normal subjects of matched control group were studied. In all IVGTT was performed. 19 patients with normal K values were randomized to treated with either propranolol 160 mg daily (10 persons) or acebutolol 400 mg daily (9 persons). 12 patients with low K values were randomized to treated with either propranolol (5 persons) or acebutolol (7 persons). After 7 days on treatment a second IVGTT was carried. In all blood samples were glucose, FFA and insulin levels determined, in samples taken at 0 T3 and T4 too. T3, T4 and insulin were measured by the radioimmunoassay, glucose by the glucose oxidase method, FFA by the colorimetric method. In hyperthyroid patients with low K value significantly higher plasma concentrations of FFA were found compared to control and after propranolol or acebutolol treatment no differences in FFA levels between hyperthyroid patients and control were observed. In patients with low K value acebutolol but not propranolol normalized K value and propranolol but not acebutolol significantly decreased acute phase of insulin secretion. In patients with normal K value plasma glucose and insulin concentrations as well K value were not altered during propranolol or acebutolol treatment. CONCLUSIONS: 1. Hyperthyroid patients with low K value differ from healthy subjects higher plasma FFA levels, 2.(ABSTRACT TRUNCATED AT 250 WORDS)

Acebutolol↗

[Prevalence of hypothyroidism and hyperthyroidism in temporal arteritis and rhizomelic pseudopolyarthritis. A controlled study of 104 cases].

The aim of this study was to assess the prevalence of hyperthyroidism and hypothyroidism in giant cell arteritis and polymyalgia rheumatica. The prevalence of thyroid dysfunction in giant cell arteritis and polymyalgia rheumatica patients was determined retrospectively from 1976 through 1984 and prospectively from 1984 through 1991. A control group was composed of patients over 55 years of age consecutively admitted to the same hospital department for another condition. Patients were screened for thyroid dysfunction using a thyrotropin assay. Abnormal results were evaluated by T3 and T4 assays and, if needed, a TRH test. Among the 68 giant cell arteritis patients (mean age 72.6 +/- 7 years), of which 41 were included in the prospective arm of the study, 6 had hypothyroidism and 3 had hyperthyroidism. Corresponding figures were 4 and 4 among the 36 patients with polymyalgia rheumatica (mean age 71.7 +/- 8.3 years), of which 18 were evaluated prospectively. Among the 305 controls (mean age 71.6 +/- 9.4 years), 16 had hypothyroidism and 10 had hyperthyroidism. Prevalences of hypothyroidism, hyperthyroidism, and antithyroid antibodies were not significantly different in the control and case groups. Data fail to support previous suggestions that giant cell arteritis or polymyalgia rheumatica patients may be an increased risk for hypothyroidism or hyperthyroidism. They lend no indirect support to the hypothesis that giant cell arteritis and polymyalgia rheumatica may be autoimmune disorders.

Aged↗

The relationship between serum triiodothyronine and thyroxine concentrations in hyperthyroidism.

In toxic nodular goitre relapses of hyperthyroidism after medical therapy probably are more common than in toxic diffuse goitre. It has also been reported that in patients with toxic diffuse goitre a high ratio of triiodothyronine (T3) and thyroxine (T4), initially or during medical treatment, predicts a relapse of the hyperthyroidism after cessation of therapy. We therefore studied the relationship between T3 and T4 in untreated patients with toxic diffuse goitres (n = 46, mean ratio T3/T4 29.6 nmol/mumol +/- 10.7 SD) and toxic nodular goitres (n = 12, ratio 29.3 +/- 17.1), and found no significant difference. Both groups differ significantly from normal controls (n = 16, ratio 14.6 +/- 1.5, P < 0.01). From the patients with toxic diffuse goitres we compared two groups. Patients in the first group remained in remission after short-term medical treatment (n = 10); the second group contains patients with a relapse of hyperthyroidism (n = 10). Differences between both groups in the median ratio of T3 and T4 were assessed before the start of treatment, at 4 and at 8 weeks. No significant differences were found between the two groups. The ratio of T3 and T4 is not helpful in distinguishing diffuse and multinodular toxic goitre or in determining the prognosis after medical treatment of hyperthyroidism caused by a hyperfunctioning thyroid gland. However, recurrence of hyperthyroidism was found in 3 patients with a T3/T4 ratio > 60 nmol/mumol after 8 weeks of treatment.

Adult↗

Effects of propylthiouracil on intestinal transit time and symptoms in hyperthyroid patients.

BACKGROUND/AIMS: Gastrointestinal disturbances such as diarrhea and malabsorption with steatorrhea may show up in hyperthyroid patients. The aim of our study was to evaluate oro-caecal transit time (OCTT) and gastrointestinal symptoms in hyperthyroid patients before and after propylthiouracil administration. MATERIALS AND METHODS: Twenty hyperthyroid patients (15 Females and 5 Males, mean age 47 years) were studied. Eight of them had diarrhea and 10 steatorrhea. The control group was composed of 20 healthy volunteers (13 F and 7 M, mean age 49 yrs). OCTT and fecal fat excretion were measured before and after propylthiouracil administration (300 mg/day for 10 day and then 200 mg/day for 30 days). RESULTS: Before the treatment in hyperthyroid patients had began the mean OCTT was significantly lower than in the control group (64 min. versus 107 min; p < 0.0001). After treatment mean OCTT became similar to the controls (p = ns); diarrhea disappeared in all affected patients and mean fecal fat excretion was reduced from 7.9 gr/24h to 3.4 gr/24h, with a statistically significantly difference (p < 0.0001). CONCLUSIONS: The treatment with propylthiouracil induces the normalization of thyroid hormone status and consequently of OCTT with the disappearance of gastrointestinal symptoms, such as diarrhea and steatorrhea, with a better efficacy if compared to other drugs utilized in the treatment of hyperthyroidism.

Administration, Oral↗

Effect of hyperthyroidism on antral myoelectrical activity, gastric emptying and dyspepsia in man.

BACKGROUND/AIMS: The objective of the present study was to investigate the effect of hyperthyroidism on antral myoelectrical activity, gastric emptying and dyspepsia in man. METHODOLOGY: Twenty-three patients with manifest hyperthyroidism and dyspepsia confirmed by a standardized protocol were studied by electrogastrography (EGG). The following EGG parameters were determined: dominant frequency (DF cycles per minute (cpm), DF (%) in the normal range (2-4 cpm)), bradygastria (< 2 cpm), tachygastria (4-10 cpm), dominant frequency instability coefficient (DFIC), and postprandial to fasting power ratio. Data were correlated to results obtained in 18 age- and gender-matched controls. In 10 patients, a control measurement was performed after antithyroid therapy. In addition, in 15 consecutive patients, EGG data were compared to gastric emptying of radionuclides recorded simultaneously (gamma camera). RESULTS: Hyperthyroid patients revealed a significant increase in preprandial DF, and in pre- and post-prandial tachygastrias compared to controls (3.3 cpm vs 3.1 cpm; 8.8% vs 3.5%; 12.3% vs 3.5%; p < 0.05). After antithyroid therapy, postprandial tachygastrias were reduced significantly. About 50% of the patients exhibited delayed gastric emptying compared to previously evaluated normal values (t 60 nuclide retention: > 68%). However, these patients did not differ in tachygastria and the other EGG parameters from those with normal gastric emptying (p > 0.05). Both EGG and radioscintigraphy did not correlate significantly with dyspepsia. CONCLUSIONS: Dyspeptic patients with hyperthyroidism frequently display tachygastria and delayed gastric emptying. However, tachygastria has no important effect on gastric motor activity in hyperthyroidism.

Aged↗

[Three cases of thymic hyperplasia associated with hyperthyroidism].

We encountered three cases of thymic hyperplasia associated with hyperthyroidism. Case 1 was in a 35-year-old woman; a chest CT scan showed an anterior mediastinal mass and right-sided pleural effusion, which suggested the presence of a thymoma Case 2 was in a 21-year-old man who complained of palpebral ptosis and also had myasthenia gravis (Osserman type I). Case 3 was in a 47-year-old woman; a chest CT scan showed thymic hyperplasia and mediastinal lymphadenopathy. In all cases, anti-thyroid medication was given first, because of the associations with hyperthyroidism. Moreover, in cases 1 and 2 no tumor was found, and only hyperplasia was detected in the thymus, although both patients underwent extended thymectomy. Furthermore, surgery was not effective against the hyperthyroidism (anti-thyroid medication could not be withdrawn or reduced). In cases 2 and 3, thymic hyperplasia, as seen on chest CT scans, resolved as thyroid function was normalized by anti-thyroid medication. The pretracheal lymphadenopathy seen in case 3 also resolved. Thymic hyperplasia may have been a result, not a cause, of hyperthyroidism. When we encounter patients with thymic masses and hyperthyroidism, we should give anti-thyroid medication and observe the thymus for some time before resorting to surgery.

Adult↗

Auditory even-related brain potentials in hyperthyroidism.

Several studies based on psychometric tests have demonstrated an impairment of cognitive functions in hyperthyroid patients. Long-latency auditory event related potentials (ERPs) allow the measurement of a kind of cerebral reaction time that is unavailable to psychometric tests. However, ERPs alterations in hyperthyroidism have been investigated only in experimentally induced hyperthyroidism in healthy subjects, but no study has reported on thyrotoxic patients so far. Therefore, we investigated alterations of P300 wave latency in hyperthyroid patients before and after antithyroid treatment. ERPs were elicited in 20 untreated patients with hyperthyroidism (mean age: 27.40 +/- 2.10 years) and in 30 sex-, age- and education-matched controls. ERPs recordings were repeated 4 months after attainment of euthyroidism. Untreated patients had longer mean P300 latencies when compared to those in controls (338.3 +/- 26.6) vs 320.7 +/- 16.2 msec, P = 0.020). Slowing of P300 latency was marked in 4 of 20 patients and its normalization was observed after treatment. The mean P300 latencies also returned to normal (320.5 +/- 15.5 msec) 4 months after achievement of euthyroidism. Our study shows that P300 is normal in most cases, while we have found in a subgroup of patients a small but statistically significant slowing. However, these alterations are reversed 4 months after attainment of euthyroidism.

Adult↗

[Incidence and functional role of antithyroid antibodies in hyperthyroidism].

INTRODUCTION: We report our personal experience in patients with biochemical hyperthyroidism and no nodules, studying the correlations between antithyroid autoantibodies titers, thyroid function and clinical symptoms. MATERIAL AND METHODS: We examined 93 patients (13 men and 80 women, mean age: 44.6 years, range: 25-68 years) referred for suspected hyperthyroidism. Thyroid 99mTc scintigraphy was performed and the 20 minutes' uptake index (UI) calculated: all these patients had a scintigraphic pattern of normal or enlarged thyroid with homogeneous radiotracer uptake. The presence and titer of antiperoxidase (TPO) and anti-TSH receptor antibodies (TRAB), FT3, FT4, TSH were assayed. Based on the results, the patients were divided into 4 subgroups: A (high TRAB/high TPO, no. 17), B (low TRAB/high TPO, no. 15), C (high TRAB/low TPO, no. 35), D (low TRAB/low TPO, no. 26). The incidence of hyperthyroidism symptoms was 94% in Group A, 40% in Group B, 89% in Group C, 50% in group D. RESULTS: UI significantly correlated with FT3 (p < .001), FT4 (p < .01) and TRAB (p < .01) titers. FT3 and UI average values were significantly higher in Group A and Group C patients (high TRAB) than in Group B and Group D patients (low TRAB) (p < .01); these parameters were significantly higher also in Group A than in Group B patients (p < .05 for FT3 and p < .03 for UI, respectively). Mean intergroup TSH values did not differ (p = ns) and anti-TPO antibodies did not correlate with FT3, FT4 and TSH titers. CONCLUSIONS: UI behaved as a good marker of hyperthyroidism in all patients and TRAB correlated well with organ function and the clinical picture; however, about 18% of patients exhibited no antibody production. No correlation was found between TPO and thyroid function. The lack of antithyroid antibodies seems to indicate a better clinical course for hyperthyroidism. The patients without TRAB and/or with high anti-TPO titers may follow different clinical courses and need a regular follow-up.

Adult↗

[Hyperthyroidism induced by iodinated roentgen contrast media].

Three patients with subclinical hyperthyroid goitre, women aged 63, 72 and 75 years following intravenous administration of an iodinated contrast medium developed hyperthyroidism with a marked rise of the concentration of free T4. Thyreostatic agents were unsuccessful in two patients, the third was left untreated. Hyperthyroidism improved spontaneously in all three. Iodine-induced hyperthyroidism is rare and is usually encountered in patients with a pre-existent autonomous thyroid function. Treatment of iodine-induced hyperthyroidism is essentially exclusively symptomatic. Prophylaxis with sodium perchlorate should be considered in cardiac patients with a goitre and a subnormal level of thyroid-stimulating hormone (TSH).

Aged↗

[Polyarthralgia disclosing hyperthyroidism. Two case reports].

BACKGROUND: We report two cases of rheumatism associated with hyperthyroidism. In both cases, arthralgia totally regressed after thyroid treatment. CASE REPORTS: Two 79-year-old and 59-year-old women developed manifestations of polymyalgia rheumatica and psoriasis arthritis respectively. Corticosteroid therapy was ineffective and followed by manifestations of hyperthyroidism. The first patient was treated with carbimazole and the second with thyroidectomy. Once the hyperthyroidism was controlled, both patients experienced a dramatically rapid cure of their arthralgias. DISCUSSION: Scalpulo-humeral periarthritis is the main articular complication of hyperthyroidism. True manifestations of "thyrotoxicosis rheumatism" are unusual and may be linked with a direct toxicity of the thyroid hormones on joint cartilage or with an autoimmune manifestation of hyperthyroidism.

Adrenal Cortex Hormones↗